Reagent Proteins: Reagent Proteins is the Source for Proteins. Supplying over 5,000 quality reagent proteins, specialized products and vaccine components. Formerly sold under the Reagent Proteins division of Pfenex, CRM197 is the ideal carrier protein or immunological adjuvant for conjugate vaccines.  CRM197 has been used commercially in prophylactic vaccines since 1990.  Current research and development areas include immunotherapies and anti-addiction vaccines.  Pfenex CRM197 is similar in both structure and function to the protein produced in C. diphtheriae, as shown in physicochemical and in vivo studies.
-
DATE: April 28, 2020 TIME: 9:00am PT, 12:00pm ET The Baculovirus Expression Vector System is a versatile platform for expression of individual recombinant proteins, membrane proteins, virus-...
The International Council for Standardization in Haematology (ICSH) is a nonprofit organization dedicated to providing open-access guidance documents to enhance the quality of laboratory tes...
APR 22, 2020 | 8:00 AM
C.E. CREDITS
Discover strategies for labs to optimize coagulation testing, improve patient outcomes, and strengthen their role in clinical care teams....
APR 20, 2020 | 8:00 AM
C.E. CREDITS
Explore emergency hemostasis testing approaches, from rapid lab assays to viscoelastic methods, for managing bleeding patients....
DATE: April 16, 2020 TIME: 9:00am PT, 12:00pm ET There is an increasing need to evaluate and understand unique phenotypes and mechanisms of action within the tumor microenvironment. Existing...
Neurodegenerative disease research can be considerably accelerated by using fibrillar or oligomeric constructs of prion-like proteins in in vitro or in vivo studies. These exist in a variety...
Whether you are performing killing assays, characterizing the tumor microenvironment, or investigating immunogenicity, primary cells are essential for the discovery of new therapeutics. Conc...